TrialEuropean journal of epidemiology2017
A randomized trial of early detection of clinically significant prostate cancer (ProScreen): study design and rationale.
Anssi Auvinen et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
29 papers cite it
this paperpooled ittrialcites it